Cardurion Pharmaceuticals has filed a notice of an exempt offering of securities to raise $17,500,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Cardurion Pharmaceuticals is raising $17,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Peter Lawrence played a key role in…